Enhancing & Accelerating International
Oncology Research & Treatment

HOME      IBPC OVERVIEW    STAFF & SERVICES      CONTACT US

 

 

  • Over 30,000 new cancer patients are treated annually within the IBPC network.

  • Our IBPC Patient Database enables Oncopartners to pre-screen eligible patients to enhance enrollment rates.

  • Oncopartners central office in São Paulo provides study planning, accelerated start-up, quality assurance, technology infrastructure, and project oversight.

  • Our staff is comprised of experienced, multi-lingual clinical research specialists and includes a full-time Medical Oncologist.

  • We offer dependable compliance with international regulatory requirements and leading standards for research and data quality.

  • We offer a comprehensive suite of study management services.

Co-operative group excellence… private sector performance

Oncopartners US
330 East 39th Street, PHN
New York, NY  10016
Tel: 212-922-9013
Fax: 212-922-9014

Oncopartners Brazil
Rua Cincinato Braga, 37
Cjto. 82 Bela Vista
01333-011   São Paulo,  SP
Tel: (55-11) 2198-0515

 

Oncopartners and IBPC (Instituto Brasileiro de Pesquisa em Câncer) have created a new strategy for enhancing global clinical oncology research by providing sponsors with well-controlled access to Brazil’s extensive patient population.  Eighty percent of Brazil’s 190 million citizens are served by the public healthcare system.  The country’s leading oncologists, highly motivated to participate in research which offers access to treatments and compounds otherwise unavailable through the public system’s formulary, formed IBPC.  Based in Princeton, NJ and São Paulo, Brazil, Oncopartners has made significant investments in assembling a team of international industry veterans supported by a customized IT infrastructure, robust SOPs, and active participation by leading oncologists throughout Brazil.  As exclusive partners with the premier network of public hospitals in Brazil, we are confident that our services and expertise will enable you to significantly increase the enrollment rate for Phase II and III studies and will ensure that data from the Brazilian sites is of the highest quality.  We work with our pharma, biotech, and CRO clients to identify the best solutions for their specific needs.

Oncopartners was created in response to the growing need for high-performing oncology investigative sites and to complement IBPC’s mission to provide expanded treatment options for oncologists and patients in Brazil’s public healthcare system.  The rapid expansion of international oncology clinical trials has far exceeded the capacity of leading research centers in Europe and North America which has resulted in slower patient accrual, longer timelines and escalating study costs per patient.  The expertise of our staff, combined with our international infrastructure, enables Oncopartners to leverage our relationships with IBPC and leading private hospitals in Brazil to offer our clients compelling solutions to their enrollment challenges.

 

   Copyright © 2007 CENTER NORTH. All rights reserved.